PARIS, Jan. 27, 2012 /NEWS.GNOM.ES/ – IMCAS – Merz Aesthetics today releases further intriguing insights uncovered by its ‘Face Value’ Beauty Report. Four out of five surveyed European women think that it’s ‘the norm’ to spend money on aesthetic procedures like dermal fillers, botulinum toxins, and laser treatments to maintain their looks as they grow older. No longer just reserved for the super-rich or Hollywood elite, two thirds of the respondents admit that they will have a procedure at some point in their adult lives.
Vanillaesthetics new website is now live providing information on treatments for anti-ageing, anti-wrinkle, lip augmentation, cheek augmentation, liquid facelift, skin smoothing, crows feet removal, and general beauty enhancement. Please visit the new website and have a look around.
Juvéderm
Juvéderm (pronounced /ˈdʒuːvɨdɜrm/), one of the newest of the so-called “injectable fillers,” is used by cosmetic, dermatological and plastic surgeons to soften deep folds and reduce wrinkles in the faces of patients. The substance is largely hyaluronic acid, a substance normally found in the skin, muscles, and tendons of mammals. Approved in June 2006 by the U.S. Food and Drug Administration, Juvéderm’s prime use is removing nasolabial folds, or “smile lines,” creases of skin which run from the corners of the nose to the corners of the mouth. It is also used as a lip augmentation agent, and to fill in hollow places and scars on the face. However, all hyaluronic acid facial filler products are eventually absorbed by the body, usually within six to nine months, causing the patient to undergo repeat injections to maintain the younger look. Juvéderm is also used by physicians to plump lips, which also lose fat and internal shape with normal aging.
History Cosmetic
The cosmetic effect of BTX-A on wrinkles was originally documented by a plastic surgeon from Sacramento, California, Dr. Richard Clark, and published in the journal Plastic and Reconstructive Surgery in 1989. Canadian husband and wife ophthalmologist and dermatologist physicians Carruthers JD and Carruthers JA were the first to publish a study on BTX-A for the treatment of glabellar frown lines in 1991. Similar effects had reportedly been observed by a number of independent groups (Brin, and the Columbia University group). After formal trials, on April 12, 2002, the FDA announced regulatory approval of botulinum toxin type A (Botox Cosmetic) to temporarily improve the appearance of moderate-to-severe frown lines between the eyebrows (glabellar lines). Subsequently, cosmetic use of botulinum toxin type A has become widespread with many celebrities viewing it as less intrusive and/or artificial than other types of plastic surgery. The results of cosmetic procedures vary but can last up to eight months.
Botulinum toxin
From Wikipedia, the free encyclopedia
Botulinum toxin is a protein produced by the bacterium Clostridium botulinum, and is extremely neurotoxic. When introduced intravenously in monkeys, type A (Botox Cosmetic) of the toxin exhibits an LD50 of 40-56 ng, type C1 around 32 ng, type D 3200 ng, and type E 88 ng, rendering the above types some of the most powerful neurotoxins known.Popularly known by one of its trade names, Botox or Dysport, it is used for various cosmetic and medical procedures.






Recent Comments